Yahoo! Finance Search - Finance Home - Yahoo! - Help

Monday, August 29 2016 4:14am ET - U.S. Markets open in 5 hours and 16 minutes.
Industry Center - Diagnostic Substances
Industry Center > Diagnostic Substances > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Diagnostic Substances News
Latest News
Friday, Aug 26, 2016
·Jabbing a Needle in the Overinflated Nymox Prostate Drug Hype
at TheStreet.com - Fri Aug 26
Thursday, Aug 25, 2016
·Meridian Malaria Test Wins Prestigious Innovation Award
GlobeNewswire - Thu Aug 25
·Atossa Genetics Announces Reverse Stock Split
Marketwire - Thu Aug 25
·Chembio Awarded Up to $13.2 Million U.S. Government Contract to Develop and Commercialize Point-of-Care Tests for Zika Virus
GlobeNewswire - Thu Aug 25
Wednesday, Aug 24, 2016
·Quidel to Present at 2016 Wells Fargo Healthcare Conference
Marketwire - Wed Aug 24
·Oxford Immunotec to Present at the Baird 2016 Global Healthcare Conference
Thomson Reuters ONE - Wed Aug 24
·Oxford Immunotec to Present at the Baird 2016 Global Healthcare Conference
GlobeNewswire - Wed Aug 24
·Nymox Pharmaceuticals (NYMX) Stock Surges on Long-Term Prostate Drug Trial Success
at TheStreet.com - Wed Aug 24
·Nymox Reports Successful New Long-Term Fexapotide Placebo Crossover Study Results: Major Reduction in Incidence of Surgery
GlobeNewswire - Wed Aug 24
·[$$] Trinity Biotech: Stock Has More Than 50% Upside
at Barrons.com - Wed Aug 24
Tuesday, Aug 23, 2016
·Meridian Bioscience Expands Its Portfolio and Launches First Analyte Specific Reagent (ASR) Products
GlobeNewswire - Tue Aug 23
Monday, Aug 22, 2016
·Nymox reports 2Q loss
AP - Mon Aug 22
Thursday, Aug 18, 2016
·Chembio Expands Product Distribution through Exclusive Agreement with Isla Lab in the Caribbean
GlobeNewswire - Thu Aug 18
Wednesday, Aug 17, 2016
·Baron Funds Comments on IDEXX Laboratories
- Wed Aug 17
·Quidel Receives FDA Clearance for Its Solana(R) Trichomonas Assay for Diagnosis of Trichomoniasis
Marketwire - Wed Aug 17
·Nymox Announces Private Placements of $2.24 Million
GlobeNewswire - Wed Aug 17
Tuesday, Aug 16, 2016
·CEMI: Significant Growth Opportunity in Fever Accelerating Shift From STD
- Tue Aug 16
·Surmodics to Present at 5th Annual InvestMNt Conference on August 24
Business Wire - Tue Aug 16
Friday, Aug 12, 2016
·Atossa Genetics Announces Second Quarter 2016 Financial Results and Provides Company Update
Marketwire - Fri Aug 12
Thursday, Aug 11, 2016
·Nymox Pharmaceuticals (NYMX) Stock Surges on Prostate Drug Progress
at TheStreet.com - Thu Aug 11
More Latest News...
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Diagnostic Substances Headlines
More Finance RSS Feeds


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2016, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?